Paul Rickey
Overview
Paul Rickey received an average of $898K in total compensation, including $339K in salary, at Nivalis Therapeutics from 2017 to 2021.
2021Nivalis TherapeuticsSenior Vice President and Chief Financial Officer
2020Nivalis TherapeuticsSenior Vice President and Chief Financial Officer
2019Nivalis TherapeuticsSenior Vice President and Chief Financial Officer
2018Nivalis TherapeuticsSenior Vice President and Chief Financial Officer
2017Nivalis TherapeuticsSenior Vice President and Chief Financial Officer
Source: SEC filings on April 29, 2022, May 5, 2020, and April 24, 2018.
Related executives
We found seven more executives who work or worked at Nivalis Therapeutics.
Mitchell Gold
Nivalis Therapeutics
Chief Executive Officer
Stanford Peng
Nivalis Therapeutics
President and Head of Research and Development
Zelanna Goldberg
Nivalis Therapeutics
Chief Medical Officer
Mark Litton
Nivalis Therapeutics
Chief Operating Officer
Janice Troha
Nivalis Therapeutics
Chief Operating Officer
R Carruthers
Nivalis Therapeutics
Chief Financial Officer
Jon Congleton
Nivalis Therapeutics